Business Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto Ryan GarnerApril 19, 2022
Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
Business Numinus to enter US psychedelics market via $26.2M Novamind acquisition The transaction is expected to close around June Natalia Buendia CalvilloApril 12, 2022
Legalization Georgia advances bill to create psychedelic study group focused on Veterans’ mental health Lawmakers note that current therapeutic trials for substance use issues exclude people with a history of substance abuse Natalia Buendia CalvilloMarch 29, 2022
Business Numinus approved to study ayahuasca and San Pedro in Canada Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience Natalia Buendia CalvilloMarch 9, 2022
News Only difference between LSD and synthetic psilocybin experience is duration, researchers say But there are some physiological differences between the two Natalia Buendia CalvilloMarch 2, 2022
Canada What amendments to Canada’s restricted drug program mean for patients and practitioners The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say Natalia Buendia CalvilloJanuary 11, 2022
Psychedelics Palliative care providers see psychedelic-assisted therapy as treatment option for existential distress: study Currently treatments are largely insufficient, so care providers encourage more research despite stigma Natalia Buendia CalvilloDecember 30, 2021
Business Numinus to start trading on TSX The firm will celebrate by ringing the opening bell at the stock exchange on Thursday Kathryn TindaleDecember 15, 2021
Cannabis Consuming cannabis while on psychedelics makes the experience stronger, researchers say Cannabis and 'classical' psychedelics could act on similar receptors Natalia Buendia CalvilloNovember 4, 2021